In the Canadian medical devices industry, there were 3 M&A deals announced in Q1 2024, worth a total value of $82m, according to GlobalData’s Deals Database. The $82m acquisition of ARTMS by Telix Pharmaceuticals was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q1 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in Canada decreased by 68% in Q1 2024 compared with the previous quarter’s total of $253m and fell by 46% as compared to Q1 2023. Related deal volume remained flat in Q1 2024 versus the previous quarter and was 63% lower than in Q1 2023.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q1 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
